ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2025
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • 2020-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings
  • Abstract Number: 143 • 2018 ACR/ARHP Annual Meeting

    Aquaporin 3 (AQP3) Protein Is Highly Expressed in Psoriatic Plaques and AQP3 Gene Expression Strongly Induced By IL-23 in CD4+ Th17 Cells

    Ananta Paine1, Maria de la Luz Garcia-Hernandez2, Benjamin D. Korman2, Judilyn Duculan3, Mayte Suarez-Farinas4, James G. Krueger3 and Christopher T. Ritchlin2, 1Department of Medicine, Division of Allergy/Immunology and Rheumatology and Center for Musculoskeletal Research, School of Medicine and Dentistry, University of Rochester Medical School, Rochester, New York, USA, Rochester, NY, 2Division of Allergy/Immunology and Rheumatology and Center for Musculoskeletal Research, School of Medicine and Dentistry, University of Rochester Medical School, Rochester, New York, USA, Rochester, NY, 3Laboratory for Investigative Dermatology, Rockefeller University, New York City, New York, USA, New York City, NY, 4Icahn School of Medicine at Mount Sinai, New York City, New York, USA, New York City, NY

    Background/Purpose: Th17, a subset of CD4+ helper T cells, provides protection against pathogens and malignancies, but also promotes immune-mediated-inflammation in a range of disorders including…
  • Abstract Number: 144 • 2018 ACR/ARHP Annual Meeting

    Small Molecule Inhibitor of Bcl-6 Reduces the Tfh Population in Peripheral Blood, Splenic Germinal Center and Ankle Joints in a Collagen-Induced Arthritis Mouse Model of RA

    Nitasha Bhatia1, Sedrick Bradley2, Cara McLeod1, Gbemi Olayemi1, Robert Quinet1, William E. Davis3, Jerald Zakem4 and Xin Zhang1, 1Ochsner Medical Center, New Orleans, LA, 2Ochsner Clinic Foundation, New Orleans, LA, 3University of Queensland School of Medicine, Brisbane, Australia, 4Ochsner Medical Center, New Orleans, LA

    Background/Purpose: Rheumatoid arthritis (RA) is a common autoimmune disease characterized by chronic joint inflammation, synovial hyperplasia and progressive destruction of cartilage and bone. T follicular…
  • Abstract Number: 145 • 2018 ACR/ARHP Annual Meeting

    1,25(OH)2D3 and Dexamethasone Additively Suppress Synovial Fibroblast Activation By CCR6+ T-Helper Memory Cells and Enhance the Effect of Tnfα Blockade

    W Dankers1, C González-Leal1, N Davelaar2, P Asmawidjaja3, A Otten-Mus2, JMW Hazes4, E Colin5 and Erik Lubberts6, 1Rheumatology, Erasmus MC, Rotterdam, Netherlands, 2Rheumatology and Immunology, Erasmus MC, University Medical Center, Rotterdam, Netherlands, 3Rheumatology, Erasmus MC, University Medical Center, Rotterdam, Netherlands, 4Erasmus Medical Centre, Rotterdam, Netherlands, 5ZGT Almelo, Deventer, Netherlands, 6Erasmus Medical Center, Rheumatology, Rotterdam, Netherlands

    Background/Purpose: Despite improvement in treatment of rheumatoid arthritis (RA) over the past decades, insufficient treatment response and treatment resistance in many patients demonstrate the need…
  • Abstract Number: 146 • 2018 ACR/ARHP Annual Meeting

    Mesenchymal Stromal Cell Transferred Mitochondria Elicit an Immune Function Reprogramming That Entails T Regulatory Cell Commitment and Clinical Improvement of Graft Vs Host Disease

    Angela C. Court1, Alice Le-Gatt1, Patricia Luz-Crawford2, Monica Kurte2, Maria Ignacia Ortuzar1, Roberto Elizondo2, Rafael A. Contreras2, Karina Pino-Lagos2, Maroun Khoury3,4 and Fernando E. Figueroa4, 1Cells for Cells, Santiago, Chile, 2Laboratorio de Inmunología Celular y Molecular, Universidad de los Andes, Santiago, Chile, 3Cells for Cells, Santiago de Chile, Chile, 4Program for Translational Research in Cell Therapy, Universidad de los Andes, Santiago de Chile, Chile

    Background/Purpose: Mesenchymal stromal cells (MSCs) are progenitor cells with suppressive capacities that have fueled ample translation for the treatment of immune mediated diseases including Graft…
  • Abstract Number: 147 • 2018 ACR/ARHP Annual Meeting

    T Follicular Helper Cell Phenotype in RA Patients Receiving Rituximab

    Betty Hsiao1, Jin-Young Choi2 and Joseph E. Craft3, 1Yale University School of Medicine, New Haven, CT, 2Section of Rheumatology, Department of Internal Medicine, Yale University School of Medicine, New Haven, CT, 3Department of Internal Medicine/Rheumatology, Yale University School of Medicine, New Haven, CT

    Background/Purpose: B and T cells contribute to tissue injury in rheumatoid arthritis (RA). Rituximab (RTX), an anti-CD20 monoclonal antibody, is used for the treatment of…
  • Abstract Number: 148 • 2018 ACR/ARHP Annual Meeting

    High Level of CD38 Expression in SLE CD8 T Cells Dictates Decreased Cytotoxicity

    Eri Katsuyama, Abel Suarez-Fueyo, Sean Bradley, Michihito Kono, Lama Mulki, Vasileios C. Kyttaris and George C Tsokos, Rheumatology, Department of Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, Boston, MA

    Background/Purpose: CD38 is an ectonucleotidase that has the ability to degrade nicotinamide adenine dinucleotide (NAD). The percentage of CD38 expressing CD8 T cells are increased…
  • Abstract Number: 149 • 2018 ACR/ARHP Annual Meeting

    Deep Immune-Profiling of CD4+ T Cells in Behçet’s Disease

    Johannes Nowatzky1, Arshed Al-Obeidi2, Yuhe Xia2 and Olivier Manches3, 1Department of Medicine, Division of Rheumatology, NYU School of Medicine, New York, NY, 2NYU School of Medicine, New York, NY, 3INSERM, Grenoble, France

    Background/Purpose: Functionality and immune-phenotypes of the human CD4+ T-cell compartment in Behçet’s disease (BD) are under-investigated, but several lines of evidence point to its relevance…
  • Abstract Number: 150 • 2018 ACR/ARHP Annual Meeting

    PD-1 Signaling Interferes with OX40L to Alter the Suppressive Function and Proliferation of CD4+ Regulatory T Cells in Lupus Mice

    Maida Wong1 and Bevra H Hahn2, 1Division of Rheumatology, Tibor Rubin Veterans Affairs Medical Center Long Beach, Long Beach, CA, 2Rheumatology, UCLA David Geffen School of Medicine, Los Angeles, CA

    Background/Purpose: In systemic lupus erythematosus (SLE), the dysregulated production of autoantibodies is a consequence of disrupted T cell homeostasis. Programmed death-1 (PD-1), a negative regulator…
  • Abstract Number: 151 • 2018 ACR/ARHP Annual Meeting

    Molecular Mechanisms of Pathogenic T Cell Resilience in Human Arthritis

    Pavanish Kumar1, Jing Yao Leong1, Bhairav Paleja1, Suzan Saidin1, jorg van Loosdregt1, Thaschawee Arkachaisri2, Alessandro Consolaro3, Marco Gattorno4, Alberto Martini5, Gary W Williams6, Ken D Pischel6, Martin Lotz7 and Salvatore Albani8, 1Translational Immunology Institute, Singhealth/Duke-NUS Academic Medical Centre, Singapore, Singapore, 2KK Women's and Children's Hospital, Singapore, Singapore, 3Second Paediatric Division, University of Genoa and G Gaslini Institute, Genova, Italy, Genova, Italy, 4Second Paediatric Division, University of Genoa and G Gaslini Institute, Genova, Italy, Genoa, Italy, 5Pediatric Rheumatology International Trial Organization (PRINTO) Coordinating Centre, Genoa, Italy, 6Scripps Clinic, La Jolla,, California, CA, 7Department of Molecular & Experience Medicine, Scripps Research Institute, LaJolla, CA, 8Translational Immunology Institute, Singhealth/Duke-NUS Acedemic Medical Centre, Singapore, Singapore

    Background/Purpose: T-cell resilience is critical to the immune pathogenesis of human autoimmune arthritis. Autophagy is essential for memory T cell generation and is associated with…
  • Abstract Number: 152 • 2018 ACR/ARHP Annual Meeting

    Polymorphonuclear Neutrophils and Regulatory T Lymphocytes (Treg) Cooperate to Sustain Treg Activity in Normal and Arthritic Contexts

    Maxime Batignes1, François Santinon1, Marie-Christophe Boissier2,3, Patrice Decker4 and Natacha Bessis1, 1INSERM UMR 1125 University of Paris 13, Sorbonne Paris Cité, Bobigny, France, 2University of Paris 13,Sorbonne Paris Cité, Bobigny, France, 3Rheumatology Department, Assistance Publique – Hôpitaux de Paris (AP-HP), Avicenne Hospital, Bobigny, France, 4Inserm UMR 1125, Li2P, University of Paris 13, Sorbonne Paris Cité, Bobigny, France

    Background/Purpose: Polymorphonuclear neutrophils (PMN) are abundant and activated in rheumatoid arthritis (RA) joints. In addition to their pro-inflammatory role, PMN exert immunoregulatory functions and may…
  • Abstract Number: 153 • 2018 ACR/ARHP Annual Meeting

    Chemotaxis of Vδ2 T Cells to the Joints Contributes to the Pathogenesis of Rheumatoid Arthritis

    Xiao Xinyue1, Wenxiu MO2 and Xuan Zhang3, 1Peking Union Medical College Hospital, Beijing, China, 2Department of Rheumatology, Peking Union Medical College Hospital, Beijing, China, 3Rheumatology, Peking Union Medical College Hospital, Beijing, China

    Background/Purpose: To explore the role of Vδ2 t cells in the pathogenesis of rheumatoid arthritis (rA) Methods: Sixty-eight patients with RA, 21 patients with osteoarthritis…
  • Abstract Number: 154 • 2018 ACR/ARHP Annual Meeting

    Epigenetic Editing of FOXP3 in Human T Cells Is Sufficient to Induce Overexpression and Create a Regulatory T Cell Phenotype in Vitro

    Christopher Dunn1, Cassandra Velasco1, Madison Andrews2, Alexander Rivas3 and Matlock A. Jeffries4, 1Rheumatology, Immunology, and Allergy, University of Oklahoma Health Sciences Center, Oklahoma City, OK, 2Oklahoma Medical Research Foundation, Oklahoma City, OK, 3University of Arkansas for Medical Sciences, Little Rock, AR, 4Arthritis and Clinical Immunology, Oklahoma Medical Research Foundation, Oklahoma City, OK

    Background/Purpose: Defects in the number and function of naturally-occurring regulatory T cells (Tregs) have been identified in a variety of autoimmune diseases. The development of…
  • Abstract Number: 155 • 2018 ACR/ARHP Annual Meeting

    Polyfunctional Synovial T-Cell Responses and Synovial Invasiveness Repressed By Blockade of Phosphodiesterase 4

    Sarah M. Wade1, Mary Canavan1, Trudy McGarry1, Siobhan C. Wade1, Ronan Mullan2, Douglas J. Veale3 and Ursula Fearon1, 1Molecular Rheumatology, School of Medicine, Trinity Biomedical Sciences Institute, Trinity College Dublin, Dublin, Ireland, 2Department of Rheumatology,, Tallaght Hospital, Dublin, Ireland, 3Centre for Arthritis and Rheumatic Diseases, Dublin Academic Medical Centre, University College Dublin, Dublin, Ireland

    Background/Purpose: Genetic and functional studies strongly support the role of T-cells in PsA pathophysiology. Effective targeting of T-cells requires a detailed understanding of their phenotypic…
  • Abstract Number: 156 • 2018 ACR/ARHP Annual Meeting

    Assessing the Role of Ascvd Score in Primary Thrombosis Prophylaxis Strategy Among Asymptomatic Antiphospholipid Antibody Carriers

    Yu Zuo1, Akrithi Udupa2, Jennifer Fan1, Una E. Makris1, David Karp1,3 and Yu-min Shen1, 1University of Texas Southwestern Medical Center, Dallas, TX, 2Internal Medicine, University of Texas Southwestern Medical Center, Dallas, TX, 3Internal Medicine/Division of Rheumatic Diseases, University of Texas Southwestern Medical Center, Dallas, TX

    Background/Purpose: Primary thrombosis prophylaxis among asymptomatic antiphospholipid antibody (aPL) carriers is challenging. The presence of aPL does not always lead to thromboembolic events. Additional factors…
  • Abstract Number: 157 • 2018 ACR/ARHP Annual Meeting

    Identifying Additional Risk Factors Associated with Thrombosis and Pregnancy Morbidity in a Unique Cohort of Antiphospholipid Antibody Positive Chinese Patients

    Yu Zuo1, Chun Li2, Song Zhang3, Una Makris1, David Karp4 and Zhan-Guo Li5, 1University of Texas Southwestern Medical Center, Dallas, TX, 2Peking University People's Hospital, Beijing, China, 3University of Texas Southwestern Medical Center, dallas, TX, 4Rheumatology, UT Southwestern Med Ctr, Dallas, TX, 5Rheum/Immunology, Peking University People's Hospital, Beijing, China

    Background/Purpose: Risk stratification of asymptomatic aPL carriers is difficult. Our objective was to identify additional clinical and epidemiological predictors of arterial thrombosis, venous thrombosis, and…
  • « Previous Page
  • 1
  • …
  • 1194
  • 1195
  • 1196
  • 1197
  • 1198
  • …
  • 2607
  • Next Page »
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

Embargo Policy

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM CT on October 25. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology